ITPR1 encodes the inositol 1,4,5-trisphosphate receptor type 1 (IP3R1), a ligand-gated calcium release channel located on the endoplasmic reticulum (ER) membrane. IP3R1 mediates calcium signaling in response to various physiological stimuli by releasing Ca²⁺ from intracellular stores into the cytoplasm. This receptor is particularly crucial in neurons where it regulates synaptic plasticity, gene expression, and cellular excitability. Mutations in ITPR1 cause spinocerebellar ataxia type 15 (SCA15), placing this gene at the intersection of cerebellar degeneration and neurodegenerative disease research[1][2].
| Inositol 1,4,5-Trisphosphate Receptor Type 1 | |
|---|---|
| Gene Symbol | ITPR1 |
| Full Name | Inositol 1,4,5-Trisphosphate Receptor Type 1 |
| Chromosome | 3p26.1 |
| NCBI Gene ID | [3708](https://www.ncbi.nlm.nih.gov/gene/3708) |
| OMIM | 147521 |
| Ensembl ID | ENSG00000150995 |
| UniProt ID | [Q14643](https://www.uniprot.org/uniprot/Q14643) |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Spinocerebellar Ataxia Type 15, [Huntington's Disease](/diseases/huntington-disease) |
ITPR1 is located on chromosome 3p26.1 and spans approximately 270 kilobases of genomic DNA. The gene contains 58 exons that undergo extensive alternative splicing to generate multiple tissue-specific and developmentally regulated isoforms[3].
| Feature | Detail |
|---|---|
| Chromosomal location | 3p26.1 |
| Genomic span | ~270 kb |
| Exon count | 58 |
| Transcript length | ~10 kb |
| Protein coding | ~8,100 bp (2,700 aa) |
The promoter region contains multiple regulatory elements including cAMP response elements (CRE), AP-1 sites, and neuron-specific enhancers that drive high expression in cerebellar Purkinje cells and hippocampal neurons.
Each IP3R1 monomer is ~2,700 amino acids with a molecular weight of ~300 kDa. Four monomers assemble to form a functional tetrameric channel[@stathopulos2003].
| Domain | Amino Acids | Function |
|---|---|---|
| N-terminal IP3-binding domain | 1-600 | Binds IP3, activation |
| Suppressor domain | 600-900 | Modulates channel activity |
| Linker/ coupling region | 900-1600 | Couples ligand binding to gate |
| Channel domain (6 TMs) | 1600-2200 | Forms Ca²⁺ pore |
| C-terminal regulatory domain | 2200-2700 | Tetramerization, gating |
IP3R1 mediates calcium-induced calcium release (CICR), a fundamental signaling mechanism in excitable cells:
IP3R1 is essential for several neuronal calcium-dependent processes:
| Region | Expression Level |
|---|---|
| Cerebellum | Very high (Purkinje cells) |
| Hippocampus | High (CA1-CA3 pyramidal cells) |
| Cerebral cortex | Moderate (Layers 2-6) |
| Basal ganglia | Moderate |
| Brainstem | Low to moderate |
SCA15 is caused by heterozygous deletions or missense mutations in ITPR1, leading to loss-of-function and Purkinje cell degeneration[2:1]:
Calcium dysregulation is a core feature of AD pathophysiology. IP3R1 alterations contribute to:
In PD, dopaminergic neurons in the substantia nigra show altered IP3R1 function:
Mutant huntingtin (mHTT) directly affects IP3R1 function:
| Strategy | Approach | Status |
|---|---|---|
| IP3R modulators | Channel agonists/antagonists | Preclinical |
| Calcium stabilizers | Restore homeostasis | Research |
| Gene therapy | Adeno-associated virus (AAV) delivery | Investigational |
| Neuroprotective | Target excitotoxicity | Research |
| Partner | Interaction | Functional Effect |
|---|---|---|
| ANK2 | Ankyrin binding | Targeting to postsynaptic sites |
| RYR1/2 | Calcium-induced calcium release | Cross-talk with ryanodine receptors |
| Homer proteins | Synaptic anchoring | Localizes to dendritic spines |
| ERp44 | Chaperone function | Quality control |
Berridge MJ. Inositol trisphosphate and calcium signalling. Nat Rev Mol Cell Biol. 2009. ↩︎
van de Leemput J, et al. Deleting the ITPR1 gene in mice and humans causes ataxia. Proc Natl Acad Sci USA. 2007. ↩︎ ↩︎
Kasahara K, et al. Molecular cloning and functional expression of rat inositol 1,4,5-trisphosphate receptor type 1. J Neurochem. 2001. ↩︎